Cereblon v patogenezi hematologických malignit – Mgr. Monika Stanková
Mgr. Monika Stanková
Bachelor's thesis
Cereblon v patogenezi hematologických malignit
Cereblon in pathogenesis of hematological malignancies
Abstract:
In this thesis, I focus on cereblon (CRBN), a protein, that plays an important role as a primary target of immunomodulatory drugs. Immunomodulatory drugs - thalidomide and it´s derivates are used as efficient therapy mainly in the treatment of multiple myeloma, the malignancy of plasma cells, which are accumulated in the bone marrow. Multiple myeloma is still considered to be an untreatable disease …moreAbstract:
V svojej bakalárskej práci sa venujem problematike cereblonu (CRBN), proteínu, ktorý v súčasnosti zastáva dôležitú úlohu ako primárny cieľ imunomodulačných liekov. Imunomodulačné lieky - talidomid a jeho deriváty sa používajú ako účinná terapia hlavne pri liečbe mnohopočetného myelómu, nádorového ochorenia plazmatických buniek akumulujúcich sa v kostnej dreni. Mnohopočetný myelóm zatiaľ ostáva ochorením …more
Language used: Slovak
Date on which the thesis was submitted / produced: 13. 5. 2014
Identifier:
https://is.muni.cz/th/izm4m/
Thesis defence
- Date of defence: 11. 6. 2014
- Supervisor: Mgr. Lenka Bešše, Ph.D.
Full text of thesis
Contents of on-line thesis archive
Published in Theses:- světu
Other ways of accessing the text
Institution archiving the thesis and making it accessible: Masarykova univerzita, Přírodovědecká fakultaMasaryk University
Faculty of ScienceBachelor programme / field:
Experimental Biology / Molecular Biology and Genetics
Theses on a related topic
- No theses on a related topic available.